{"pdb_id": "3uuo", "method": ["X-RAY DIFFRACTION"], "title": "The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia", "resolution": 2.11, "ncbi_taxon_id": 9606, "deposition_date": {"$date": "2011-11-28T00:00:00Z"}, "entity_id": "1", "entity_name": "cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A", "entity_type": "polypeptide(L)", "num_molecules": 2, "pdb_chain": "A", "struct_asym": "A"}
{"pdb_id": "3uuo", "method": ["X-RAY DIFFRACTION"], "title": "The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia", "resolution": 2.11, "ncbi_taxon_id": 9606, "deposition_date": {"$date": "2011-11-28T00:00:00Z"}, "entity_id": "1", "entity_name": "cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A", "entity_type": "polypeptide(L)", "num_molecules": 2, "pdb_chain": "B", "struct_asym": "B"}
